Skip to main content
Journal cover image

Preliminary validation and clinical meaning of the Cutaneous Assessment Tool in juvenile dermatomyositis.

Publication ,  Journal Article
Huber, AM; Dugan, EM; Lachenbruch, PA; Feldman, BM; Perez, MD; Zemel, LS; Lindsley, CB; Rennebohm, RM; Wallace, CA; Passo, MH; Reed, AM ...
Published in: Arthritis Rheum
February 15, 2008

OBJECTIVE: To provide preliminary validation of the Cutaneous Assessment Tool (CAT), a new tool to assess cutaneous manifestations of juvenile dermatomyositis (DM), and to explore the clinical meaning of CAT scores. METHODS: Children with juvenile DM (n = 113) were assessed at baseline and 7-9 months later (n = 94). Internal consistency, redundancy, construct validity, and responsiveness of the CAT were examined. CAT scores corresponding to ordinal global assessments were determined. RESULTS: Item-total correlations ranged from 0.27-0.67 for activity lesions present in > or =10% of patients; item-domain and domain-total correlations ranged from 0.25-0.99. Cronbach's alpha was 0.79 for the CAT activity score and 0.74 for the CAT damage score. As predicted, the CAT activity score correlated strongly with both global disease activity and skin disease activity and moderately with the Childhood Myositis Assessment Scale, whereas the CAT damage score correlated moderately with the physician global disease and skin disease damage scores. Median CAT activity scores of 1, 7, 13, 18, and 31 corresponded to absent, mild, moderate, severe, and extremely severe skin disease activity, respectively. Median CAT damage scores of 0, 1, 2, and 5 correlated with the same descriptions of damage (severe and extremely severe combined). CONCLUSION: Preliminary validation of the CAT demonstrated good internal consistency, nonredundancy, good construct validity, and appropriate responsiveness. The CAT is a comprehensive, semiquantitative assessment tool for skin disease in juvenile DM.

Duke Scholars

Published In

Arthritis Rheum

DOI

ISSN

0004-3591

Publication Date

February 15, 2008

Volume

59

Issue

2

Start / End Page

214 / 221

Location

United States

Related Subject Headings

  • Skin
  • Severity of Illness Index
  • Reproducibility of Results
  • Pilot Projects
  • Myositis
  • Humans
  • Follow-Up Studies
  • Dermatomyositis
  • Chronic Disease
  • Child
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Huber, A. M., Dugan, E. M., Lachenbruch, P. A., Feldman, B. M., Perez, M. D., Zemel, L. S., … Juvenile Dermatomyositis Disease Activity Collaborative Study Group. (2008). Preliminary validation and clinical meaning of the Cutaneous Assessment Tool in juvenile dermatomyositis. Arthritis Rheum, 59(2), 214–221. https://doi.org/10.1002/art.23340
Huber, Adam M., Elizabeth M. Dugan, Peter A. Lachenbruch, Brian M. Feldman, Maria D. Perez, Lawrence S. Zemel, Carol B. Lindsley, et al. “Preliminary validation and clinical meaning of the Cutaneous Assessment Tool in juvenile dermatomyositis.Arthritis Rheum 59, no. 2 (February 15, 2008): 214–21. https://doi.org/10.1002/art.23340.
Huber AM, Dugan EM, Lachenbruch PA, Feldman BM, Perez MD, Zemel LS, et al. Preliminary validation and clinical meaning of the Cutaneous Assessment Tool in juvenile dermatomyositis. Arthritis Rheum. 2008 Feb 15;59(2):214–21.
Huber, Adam M., et al. “Preliminary validation and clinical meaning of the Cutaneous Assessment Tool in juvenile dermatomyositis.Arthritis Rheum, vol. 59, no. 2, Feb. 2008, pp. 214–21. Pubmed, doi:10.1002/art.23340.
Huber AM, Dugan EM, Lachenbruch PA, Feldman BM, Perez MD, Zemel LS, Lindsley CB, Rennebohm RM, Wallace CA, Passo MH, Reed AM, Bowyer SL, Ballinger SH, Miller FW, Rider LG, Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Preliminary validation and clinical meaning of the Cutaneous Assessment Tool in juvenile dermatomyositis. Arthritis Rheum. 2008 Feb 15;59(2):214–221.
Journal cover image

Published In

Arthritis Rheum

DOI

ISSN

0004-3591

Publication Date

February 15, 2008

Volume

59

Issue

2

Start / End Page

214 / 221

Location

United States

Related Subject Headings

  • Skin
  • Severity of Illness Index
  • Reproducibility of Results
  • Pilot Projects
  • Myositis
  • Humans
  • Follow-Up Studies
  • Dermatomyositis
  • Chronic Disease
  • Child